Sodium Awareness for Premature Birth
(SALT Trial)
Trial Summary
What is the purpose of this trial?
SALT is a multi-centre, non-blinded, non-randomized prospective interventional pilot study teaching lactating parents of hospitalized preterm infants how to test their breastmilk sodium (Na) using point-of-care (POC) meters. A drop in Na is a sign of secretory activation in the breast that is associated with adequate short and long-term breast milk volumes in this vulnerable population.Primary Objective: Establish feasibility, acceptance, and time cost of parent-led parent milk Na testing in the first 14 days postpartumSecondary Objective: Further investigate relationships between pumping behaviours, lactation risk factors, daily milk Na and lactation outcomesExploratory Objective: Explore how POC Na data may be used to modify pumping behaviour and milk volumes
Research Team
Samantha J. Anthony, PhD
Principal Investigator
The Hospital for Sick Children
Eligibility Criteria
The SALT study is for lactating parents with preterm infants (<35 weeks gestation) in the NICU. Participants must consent, be within 5 days postpartum, plan to pump breast milk for at least 2 weeks, and expect their infant's NICU stay to be over a week.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants are taught to test their breastmilk sodium using point-of-care meters and modify pumping behavior based on sodium levels
Follow-up
Participants are monitored for lactation outcomes and milk provision at NICU discharge
Treatment Details
Interventions
- Parent-led Parent Milk Sodium Testing
Find a Clinic Near You
Who Is Running the Clinical Trial?
The Hospital for Sick Children
Lead Sponsor
University of Washington
Collaborator